HKD 3.02
(-1.31%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.08 Billion HKD | 34.0% |
2022 | 810.65 Million HKD | -2.04% |
2021 | 827.5 Million HKD | 29.64% |
2020 | 638.3 Million HKD | 25.92% |
2019 | 506.92 Million HKD | 10.29% |
2018 | 459.63 Million HKD | 12.18% |
2017 | 409.72 Million HKD | 44.64% |
2016 | 283.27 Million HKD | -1.89% |
2015 | 288.71 Million HKD | 0.02% |
2014 | 288.66 Million HKD | -28.71% |
2013 | 404.91 Million HKD | 1.54% |
2012 | 398.75 Million HKD | 16.49% |
2011 | 342.31 Million HKD | 14.64% |
2010 | 298.6 Million HKD | 30.18% |
2009 | 229.37 Million HKD | 1.59% |
2008 | 225.78 Million HKD | 18.63% |
2007 | 190.31 Million HKD | 123.24% |
2006 | 85.25 Million HKD | -4.97% |
2005 | 89.71 Million HKD | 17.91% |
2004 | 76.08 Million HKD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1.14 Billion HKD | 0.0% |
2023 FY | 1.08 Billion HKD | 34.0% |
2023 Q4 | 1.08 Billion HKD | 0.0% |
2023 Q2 | 1 Billion HKD | 0.0% |
2022 Q4 | 810.65 Million HKD | 0.0% |
2022 FY | 810.65 Million HKD | -2.04% |
2022 Q2 | 847.11 Million HKD | 0.0% |
2021 FY | 827.5 Million HKD | 29.64% |
2021 Q4 | 827.5 Million HKD | 0.0% |
2021 Q2 | 746.89 Million HKD | 0.0% |
2020 Q2 | 603.76 Million HKD | 0.0% |
2020 FY | 638.3 Million HKD | 25.92% |
2020 Q4 | 638.3 Million HKD | 0.0% |
2019 Q2 | 446.23 Million HKD | 0.0% |
2019 Q4 | 506.92 Million HKD | 0.0% |
2019 FY | 506.92 Million HKD | 10.29% |
2018 Q4 | 459.63 Million HKD | 0.0% |
2018 FY | 459.63 Million HKD | 12.18% |
2018 Q2 | 401.88 Million HKD | 0.0% |
2017 Q4 | 409.72 Million HKD | 0.0% |
2017 FY | 409.72 Million HKD | 44.64% |
2017 Q2 | 326.34 Million HKD | 0.0% |
2016 Q4 | 283.27 Million HKD | 0.0% |
2016 FY | 283.27 Million HKD | -1.89% |
2016 Q2 | 295.15 Million HKD | 0.0% |
2015 FY | 288.71 Million HKD | 0.02% |
2015 Q4 | 288.71 Million HKD | 0.0% |
2015 Q2 | 274.36 Million HKD | 0.0% |
2014 Q2 | 361.48 Million HKD | 0.0% |
2014 Q4 | 279.55 Million HKD | 0.0% |
2014 FY | 288.66 Million HKD | -28.71% |
2013 Q4 | 404.91 Million HKD | 0.0% |
2013 Q2 | 402.91 Million HKD | 0.0% |
2013 FY | 404.91 Million HKD | 1.54% |
2012 FY | 398.75 Million HKD | 16.49% |
2012 Q2 | 394.96 Million HKD | 0.0% |
2012 Q4 | 398.75 Million HKD | 0.0% |
2011 Q4 | 342.31 Million HKD | 0.0% |
2011 FY | 342.31 Million HKD | 14.64% |
2011 Q2 | 329.52 Million HKD | 0.0% |
2010 Q4 | 298.6 Million HKD | 0.0% |
2010 Q2 | 257.66 Million HKD | 0.0% |
2010 FY | 298.6 Million HKD | 30.18% |
2009 Q4 | 229.37 Million HKD | 0.0% |
2009 FY | 229.37 Million HKD | 1.59% |
2008 FY | 225.78 Million HKD | 18.63% |
2007 FY | 190.31 Million HKD | 123.24% |
2006 FY | 85.25 Million HKD | -4.97% |
2005 FY | 89.71 Million HKD | 17.91% |
2004 FY | 76.08 Million HKD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Pak Fah Yeow International Limited | 12.19 Million HKD | -8806.142% |
Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 21.774% |
Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -14852.264% |
Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -252.577% |
Qianhai Health Holdings Limited | 431.78 Million HKD | -151.579% |
Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -264.395% |
Essex Bio-Technology Limited | 62.82 Million HKD | -1629.145% |
Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -1005.451% |
PuraPharm Corporation Limited | 175.59 Million HKD | -518.622% |
JBM (Healthcare) Limited | 91.58 Million HKD | -1086.092% |
Jacobson Pharma Corporation Limited | 317.85 Million HKD | -241.752% |
China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 96.905% |